Bionext Tampere is an investment and development programme that focuses on biotechnological education, top-level research, product development, clinical application and possibilities in international commercialization.

 
 

BIOMATERIALS AND TISSUE TECHNOLOGY

Cell and tissue technology is becoming a new field in bioindustry and a third treatment line alongside medicines and surgery. Biomaterials and tissue technology are also natural areas of focus for BioneXt. The companies in the Tampere region are pioneers in research and product development in these areas.

BIO ICT

BTechnological development in several fields makes it possible to measure and analyse biological, biochemical and physiological phenomena in new ways. Microcircuits are smaller than before, new materials can be used in human organs and the operations of the human system can be measured in new ways.

IMMUNOLOGY

In recent years Tampere has become the most significant centre for vaccine and infectious disease research in Finland. The largest clinical vaccine research in our country is coordinated in the Vaccine Research Center of the University of Tampere.







Suomeksi